![]() ![]() ![]() This compares to loss of $0.09 per share a year ago. GERN - Free Report) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. 2 weeks ago - Business Wire Geron to Present at Upcoming Investor Conferences in AprilSee Geron Corporation (GERN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, to tre FOSTER CITY, Calif.- (BUSINESS WIRE)-Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 1,684,220 shares of Geron common stock.It develops a.Geron (GERN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. Radar (Ad)Geron (GERN) Outpaces Stock Market Gains: What You Should Know Feb. Radar (Ad) 4,154.87 DOW 33,976.63 The Stock That Is Flying Under Wall St. Radar (Ad) The Stock That Is Flying Under Wall St. Currency in USD Add to watchlist 2.6700 +0.1900. 25.Geron Corporation (GERN) Stock Price, News, Quote & History - Yahoo Finance Geron Corporation (GERN) NasdaqGS - NasdaqGS Real Time Price. Select time range to see more trades: Last 100 Trades. ![]() Geron (GERN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |